Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 30;97(11):e0070523.
doi: 10.1128/jvi.00705-23. Epub 2023 Oct 16.

HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in women

Affiliations

HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in women

Kirston Barton et al. J Virol. .

Abstract

The lack of a reliable method to accurately detect when replication-competent HIV has been cleared is a major challenge in developing a cure. This study introduces a new approach called the HIVepsilon-seq (HIVε-seq) assay, which uses long-read sequencing technology and bioinformatics to scrutinize the HIV genome at the nucleotide level, distinguishing between defective and intact HIV. This study included 30 participants on antiretroviral therapy, including 17 women, and was able to discriminate between defective and genetically intact viruses at the single DNA strand level. The HIVε-seq assay is an improvement over previous methods, as it requires minimal sample, less specialized lab equipment, and offers a shorter turnaround time. The HIVε-seq assay offers a promising new tool for researchers to measure the intact HIV reservoir, advancing efforts towards finding a cure for this devastating disease.

Keywords: HIV; HIV persistence; third-generation sequencing.

PubMed Disclaimer

Conflict of interest statement

J.M.F., K.B., and M.A.S. have previously received travel expenses and research consumables from Oxford Nanopore Technologies. D.M.M. has provided consultancy to Merck Research Laboratories and ViiV Healthcare outside of this work and owns common stock in Gilead Sciences. A.A.A. has received funding from Merck and Gilead for consulting. Merck and Gilead have provided her institution with funding for her research. The remaining authors have no conflict to declare.

Figures

Fig 1
Fig 1
HIVε-seq pipeline. Illustration of HIV ε-seq workflow to detect intact HIV proviral genomes. DNA is extracted from either PBMCs or CD4+ T cells, and nearly full-length PCR is performed on the extracted DNA. The reads are aligned to the HXB2 reference HIV sequence. Intact reads are inferred through the bioinformatic removal of reads containing large deletions/inversions, premature stop codons, or regulatory region defects.
Fig 2
Fig 2
Consensus congruence of amplified HIV provirus. Percent identity of a consensus sequence generated from randomly selected groups of reads containing 1, 5, 10, or 100 reads amplified from an integrated HIV-1 genome (J89GFP cell line).
Fig 3
Fig 3
HIVe-seq characterization of proviral reservoir in PLWH on ART. Characterization of the persistent proviral reservoir in CD4+ T cells or PBMCs from women (A) and men (B) chronically infected with HIV-1. Amplification—reads with both PCR binding sites. Full-length—reads mapping to greater than 8,500 bp of HXB2 reference. No stops—full length reads with no stop codons detected in protein coding regions. Intact—no stop reads without known regulatory region defects.
Fig 4
Fig 4
HIVε-seq categories by viral levels measured with QVOA and IPDA. (A) Frequency of replication-competent persistent provirus in HIV-1 infected adults on ART with fully suppressed viremia on days 15 and 19 (B) measured by the QVOA assay or (C) frequency of total DNA and intact DNA (D) as measured by IPDA compared to HIVε-seq category. No amplification—no reads map to HXB2 reference. Amplification—reads that map to HXB2 and contain 5′ and 3′ PCR primer binding sites. Full-length—reads mapping to greater than 8,500 bp of HXB2 reference. No stops—full-length reads with no stop codons detected in protein-coding regions. Intact—no stop reads without known regulatory region defects. Colors denote individual participants. Asterisks indicate P-value less than 0.05.

References

    1. Margolis DM, Archin NM. 2017. Proviral latency, persistent human immunodeficiency virus infection, and the development of latency reversing agents. J Infect Dis 215:S111–S118. doi:10.1093/infdis/jiw618 - DOI - PMC - PubMed
    1. Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong M, Lambotte O, Lamplough R, Ndung’u T, Sugarman J, Tiemessen CT, Vandekerckhove L, Lewin SR, International AIDS Society (IAS) Global Scientific Strategy working group . 2021. Research priorities for an HIV cure: international AIDS society global scientific strategy 2021. Nat Med 27:2085–2098. doi:10.1038/s41591-021-01590-5 - DOI - PubMed
    1. Bruner KM, Wang Z, Simonetti FR, Bender AM, Kwon KJ, Sengupta S, Fray EJ, Beg SA, Antar AAR, Jenike KM, Bertagnolli LN, Capoferri AA, Kufera JT, Timmons A, Nobles C, Gregg J, Wada N, Ho YC, Zhang H, Margolick JB, Blankson JN, Deeks SG, Bushman FD, Siliciano JD, Laird GM, Siliciano RF. 2019. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566:120–125. doi:10.1038/s41586-019-0898-8 - DOI - PMC - PubMed
    1. Hiener B, Horsburgh BA, Eden J-S, Barton K, Schlub TE, Lee E, von Stockenstrom S, Odevall L, Milush JM, Liegler T, Sinclair E, Hoh R, Boritz EA, Douek D, Fromentin R, Chomont N, Deeks SG, Hecht FM, Palmer S. 2017. Identification of genetically intact HIV-1 proviruses in specific CD4(+) T cells from effectively treated participants. Cell Rep 21:813–822. doi:10.1016/j.celrep.2017.09.081 - DOI - PMC - PubMed
    1. Wang Z, Simonetti FR, Siliciano RF, Laird GM. 2018. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir. Retrovirology 15:21. doi:10.1186/s12977-018-0404-7 - DOI - PMC - PubMed

Publication types